AAAAAA

   
Results: 1-10 |
Results: 10
Growth hormone treatment in short children with intrauterine growth retardation
Authors: Bundak, R Darendeliler, F Gunoz, H Bas, F Saka, N Neyzi, O
Citation: R. Bundak et al., Growth hormone treatment in short children with intrauterine growth retardation, J PED END M, 14(3), 2001, pp. 313-318
Growth of children with primary hypothyroidism on treatment with respect to different ages at diagnosis
Authors: Darendeliler, F Yildirim, M Bundak, R Sukur, M Saka, N Gunoz, H
Citation: F. Darendeliler et al., Growth of children with primary hypothyroidism on treatment with respect to different ages at diagnosis, J PED END M, 14(2), 2001, pp. 207-210
The effect of growth hormone treatment on biochemical indices in hypophosphatemic rickets
Authors: Darendeliler, F Bas, F Karaaslan, N Hekim, N Bundak, R Saka, N Gunoz, H
Citation: F. Darendeliler et al., The effect of growth hormone treatment on biochemical indices in hypophosphatemic rickets, HORMONE RES, 55(4), 2001, pp. 191-195
Summer camps for diabetic children: an experience in Antalya, Turkey
Authors: Semiz, S Bilgin, UO Bundak, R Bircan, I
Citation: S. Semiz et al., Summer camps for diabetic children: an experience in Antalya, Turkey, ACT DIABETO, 37(4), 2000, pp. 197-200
Glucocorticoid receptors in patients with congenital adrenal hyperplasia
Authors: Saka, N Guven, M Bas, F Darendeliler, F Bundak, R Gunoz, H Sultuybek, G
Citation: N. Saka et al., Glucocorticoid receptors in patients with congenital adrenal hyperplasia, J PED END M, 13(8), 2000, pp. 1101-1107
Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia dueto classic 11 beta-hydroxylase deficiency
Authors: Bas, F Saka, N Darendeliler, F Tuzlali, S Ilhan, R Bundak, R Gunoz, H
Citation: F. Bas et al., Bilateral ovarian steroid cell tumor in congenital adrenal hyperplasia dueto classic 11 beta-hydroxylase deficiency, J PED END M, 13(6), 2000, pp. 663-667
A comparison of the use of premixed insulins in pen-injectors with conventional patient-mixed insulin treatment in children and adolescents with IDDM. Is there a decreased risk of night hypoglycemia?
Authors: Arslanoglu, I Saka, N Bundak, R Gunoz, H Darendeliler, F
Citation: I. Arslanoglu et al., A comparison of the use of premixed insulins in pen-injectors with conventional patient-mixed insulin treatment in children and adolescents with IDDM. Is there a decreased risk of night hypoglycemia?, J PED END M, 13(3), 2000, pp. 313-318
HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey
Authors: Saruhan-Direskeneli, G Uyar, FA Bas, F Gunoz, H Bundak, R Saka, N Darendeliler, F
Citation: G. Saruhan-direskeneli et al., HLA-DR and -DQ associations with insulin-dependent diabetes mellitus in a population of Turkey, HUMAN IMMUN, 61(3), 2000, pp. 296-302
Deflazacort treatment in progressive diaphyseal dysplasia (Camurati-Engelmann disease)
Authors: Bas, F Darendeliler, F Petorak, I Sadikoglu, B Bilir, A Bundak, R Saka, N Gunoz, H
Citation: F. Bas et al., Deflazacort treatment in progressive diaphyseal dysplasia (Camurati-Engelmann disease), J PAEDIAT C, 35(4), 1999, pp. 401-405
Successful therapy with calcium channel blocker (nifedipine) in persistentneonatal hyperinsulinemic hypoglycemia of infancy
Authors: Bas, F Darendeliler, F Demirkol, D Bundak, R Saka, N Gunoz, H
Citation: F. Bas et al., Successful therapy with calcium channel blocker (nifedipine) in persistentneonatal hyperinsulinemic hypoglycemia of infancy, J PED END M, 12(6), 1999, pp. 873-878
Risultati: 1-10 |